4//SEC Filing
OrbiMed Capital GP V LLC 4
Accession 0000947871-20-000699
CIK 0001609550other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:24 PM ET
Size
11.5 KB
Accession
0000947871-20-000699
Insider Transaction Report
Form 4
OrbiMed Capital GP V LLC
Director
Transactions
- Sale
Common Stock, $0.001 par value
2020-08-18$108.54/sh−43,543$4,726,157→ 0 total(indirect: See Footnotes) - Sale
Common Stock, $0.001 par value
2020-08-17$107.49/sh−94,900$10,200,801→ 43,543 total(indirect: See Footnotes)
Holdings
- 1,784(indirect: See Footnotes)
Common Stock, $0.001 par value
ORBIMED ADVISORS LLC
Director
Transactions
- Sale
Common Stock, $0.001 par value
2020-08-17$107.49/sh−94,900$10,200,801→ 43,543 total(indirect: See Footnotes) - Sale
Common Stock, $0.001 par value
2020-08-18$108.54/sh−43,543$4,726,157→ 0 total(indirect: See Footnotes)
Holdings
- 1,784(indirect: See Footnotes)
Common Stock, $0.001 par value
Footnotes (5)
- [F1]These shares of the Issuer's common stock were sold in a block order at a price of $107.49.
- [F2]These shares of the Issuer's common stock are held of record by OrbiMed Private Investments V, LP ("OPI V"). OrbiMed Capital GP V LLC ("GP V") is the general partner of OPI V, and OrbiMed Advisors LLC ("Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the managing member of GP V. By virtue of such relationships, GP V and Advisors may be deemed to have voting and investment power with respect to the securities held by OPI V noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the Shares held by OPI V.
- [F3]This report on Form 4 is jointly filed by GP V and Advisors. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated a representative, currently Chau Khuong ("Khuong"), an employee of Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes.
- [F4]These shares of the Issuer's common stock were sold in a block order at a price of $108.54.
- [F5]Represents shares of the Issuer's common stock received by Khuong in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Pursuant to an agreement with Advisors and GP V, Khuong is obligated to transfer these securities, or the economic benefit thereof, to Advisors and GP V, which will in turn ensure that such securities or economic benefits are provided to OPI V.
Documents
Issuer
Inspire Medical Systems, Inc.
CIK 0001609550
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001615374
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 5:24 PM ET
- Size
- 11.5 KB